Design a defensible concentration range
Use logarithmic spacing, include controls and place observed responses on both sides of the expected midpoint whenever possible.
Move from plate quality and concentration design to an interpretable IC50 or EC50 curve without hiding the model assumptions.
For assay scientists, pharmacologists and early discovery teams.The sequence is a practical guide, not a substitute for a study-specific protocol.
Use logarithmic spacing, include controls and place observed responses on both sides of the expected midpoint whenever possible.
Review control variability and plate quality. A smooth fitted curve cannot rescue weak positive and negative control separation.
Keep the raw observations, fitted line, top, bottom, slope and midpoint visible. Treat an extrapolated midpoint as a warning, not a discovery.
For combination experiments, compare the observed combination response against an explicitly chosen independence or additivity model.
A curve is most informative when measured concentrations cover both asymptotes and the transition region.
Systematic departures from the curve can indicate a poor model, preparation error or biology not represented by a 4PL fit.
Cell line, endpoint, exposure time, normalization and fitting constraints are part of the result, not optional decoration.
A fitted value may still be returned, but it is extrapolated and usually weakly supported. Report the limitation and consider expanding the concentration range.
Only when the assay definition and prespecified analysis justify those constraints. Forced plateaus can materially shift the midpoint and slope.
No. Review data coverage, replicate behavior, parameter plausibility, residuals and whether the midpoint is bracketed.
References inform this workflow and do not imply endorsement of Tossora Lab.
Source-informed and internally checked. Independent scientific or regulatory validation is not claimed.
How we review and correct content →